We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Molitch

Mark E Molitch MD

Professor Emeritus, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Mark Molitch, M.D. is the Martha Leland Sherwin Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Northwestern University Feinberg School of Medicine.   Prior to coming to Northwestern in 1984, Dr. Molitch was an Associate Professor at Tufts University School of Medicine in Boston, Massachusetts.

Dr. Molitch earned an A.B. degree from Princeton University and an M.D. from the University of Pennsylvania.  He did his housestaff training at the Hospital of the University of Pennsylvania and an Endocrine Fellowship at the UCLA-Harbor General Hospital in Torrance, California.

Dr. Molitch has participated in clinical research for many years, focusing on the pathogenesis of pituitary tumors and their treatment as well as the complications of diabetes.  He has also had a long-standing interest in the interaction between pituitary tumors and pregnancy.  He has been involved in most of the initial trials of therapeutic agents for pituitary tumors.  He served as the Principal Investigator for the Northwestern center of the Diabetes Control and Complications Trial and of the DCCT follow-up study called “Epidemiology of Diabetes and Its Complications” (EDIC) for the Northwestern Center of the ongoing Diabetes Prevention Program Observational Study (DPPOS) and for the Prevention of Early Renal Loss (PERL) Study. Dr. Molitch has been a member of the committees that wrote many current clinical guidelines used by endocrinologists, including those for Adult Growth Hormone Deficiency, Prolactinomas, Acromegaly, Pituitary Incidentalomas, Diabetes (Standards of Care), and Diabetic Nephropathy

In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 450 original papers, review articles, book chapters, case reports and other publications.    In 1997, Dr. Molitch was the recipient of the “Outstanding Physician Educator in the Field of Diabetes Award” by the American Diabetes Association and in 2013 was the recipient of the “Distinguished Educator Award” of The Endocrine Society and was President of the Pituitary Society in 2012-2013.

Disclosures

Dr. Molitch reports research support from AstraZeneca, Bayer, NovoNordisk, Novartis and consultation Honoraria from Merck, Pfizer, Novartis.